Not intended for prophylactic use to avoid wt loss. Therapy should only be instituted after treatable causes of wt loss are sought & addressed. Patients w/ history of thromboembolic disease. Exacerbation of preexisting diabetes w/ increased insulin requirements. HIV-infected females. Greater risk of toxic reactions in patients w/ renal impairment. Women of childbearing potential should avoid becoming pregnant. May cause fetal harm when administered to pregnant women. Treatment should be discontinued in nursing mothers. Ped patients. Monitor renal function in elderly.
Sign Out
